May 26, 1987 |
"I like to have a lot of birthdays." So said Dr. Armand Hammer, chairman and CEO of Occidental Petroleum and master of U.S.-Soviet relations, who celebrated his 89th birthday Sunday with 400 close, personal friends. They kissed him, hugged him, wished him well, patted him on the back, had pictures taken with him, praised him and sang to him over the course of the five-hour-long evening at the Beverly Wilshire.
December 19, 1985 |
Turner Broadcasting System said Wednesday that it and Viacom International failed to agree on a projected joint venture at MGM/UA Entertainment and that Turner is proceeding with its original financing plan for its $1.5-billion MGM purchase. Completion of the sale is scheduled for Jan. 21. At the same time, the Atlanta-based empire of entrepreneur Ted Turner stated publicly for the first time that it might sell off everything but the film library after it acquires Culver City-based MGM.
March 5, 2012 |
In a bid to make cancer immunotherapy more effective, researchers report they have succeeded in halting the progress of aggressive melanoma in its tracks - at least briefly - in seven patients treated with an army of cloned cancer-fighting immune cells. In one of those patients, the treatment resulted in complete remission of his metastatic melanoma and evidence that his immune system stands ready to fight any return of the cancer after three years. The study, published Monday in the Proceedings of the National Academies of Science, contributes to hopes that a tumor-fighting strategy called immunotherapy can slow, halt or even reverse the growth of a range of cancers - and do so with fewer dangerous side effects.
January 31, 1989 |
A federal scientific advisory panel, which earlier this month approved the first experiments involving the transfer of genetically altered cells into humans, Monday rejected a proposal to establish an outside review committee to consider the social and ethical implications of such research.
September 15, 1996
Since the end of the Cold War, U.S. scientists have had to knock on corporate doors for the research funds once lavished on them by a government eager to maintain American technological dominance. The resulting corporate-academic partnership has produced research projects of considerable value, but not without sometimes generating bitter conflict between scientists and business.
August 10, 1989 |
As their chief accuser, a one-time undercover FBI agent, quietly watched, a dozen traders and brokers accused of cheating customers pleaded innocent Wednesday. They were charged in the government's investigation of alleged fraud at Chicago's commodities exchanges, the world's largest. All 12 once traded volatile Japanese yen futures at the Chicago Mercantile Exchange, where silver-haired FBI agent Dietrich W.
August 26, 1986 |
In what appears to be the first patent suit involving gene-splicing technology, a Thousand Oaks firm is asking a federal judge to overturn the only U.S. patents issued for a promising new anti-cancer substance called interleukin-2. The suit was filed by Amgen in U.S. District Court in San Francisco against Cetus Corp., an Emeryville, Calif., firm that holds the patents. Cetus supplied the drug, also known as IL-2, used by Dr. Steven A.
July 14, 1987 |
It is Labor Day weekend, 1997. You have some neighbors coming over for the evening (they left this morning to beat the traffic), the barbecue is stoked for an early fish fry (red meat was outlawed two years ago) and your new 80-square-foot Sony high-definition television screen is putting out a picture so sharp your kid just broke his arm trying to hug a Smurf. You know you're going to end up watching TV. The question is, what are you going to watch? You have many choices.
March 22, 1995 |
When scientists first identified the gene that causes cystic fibrosis back in 1989, those suffering from the disease suddenly had hope. Medical researchers believed it would soon be possible to replace the gene that causes the disease--the most common fatal genetic disorder affecting Caucasians--by using the new tools of biotechnology.
August 1, 1987 |
It is both heartening and depressing to note that in the midst of the summer of '87, "Snow White and the Seven Dwarfs" is at or near the top of the box-office chart. It is heartening because it proves to any sensible reader of trends that there is a hugely lucrative market for quality family movies. It's depressing because Hollywood had to dig 50 years into its past to find one.